| 货号 | ICH1211LALAPG-5mg |
|---|
| 品牌 | IchorBio |
|---|
| 描述 |
Mouse Anti-Mouse PD-1 (29F.1A12) Recombinant Antibody (LALAPG) ( ICH1211LALAPG-5mg) is a Mouse, clone 29F.1A12 (Mouse IgG2a) antibody targeting PD-1. Reactive with Mouse. Validated for Flow Cytometry, Western Blot, Blocking, IHC (Frozen).
Highlights
- ●Low Endotoxin — Suitable for in vivo and functional studies.
- ●High Purity — Minimal background for reliable results.
- ●Validated Applications — Tested in Flow Cytometry, Western Blot, Blocking, IHC (Frozen).
|
|---|
| 种属反应性 | Mouse |
|---|
| 应用 | Flow Cytometry, Western Blot, Blocking, IHC (Frozen) |
|---|
| 宿主 | Mouse |
|---|
| 克隆类型 | Recombinant |
|---|
| 同种型 | Mouse IgG2a |
|---|
| 克隆号 | 29F.1A12 |
|---|
| 免疫原 | PD-1 cDNA followed by PD-1-Ig fusion protein |
|---|
| 经测试应用 | Flow Cytometry, Western Blot, Blocking, IHC (Frozen) |
|---|
| 靶标 | PD-1 |
|---|
| 特异性 | Anti-PD-1 In Vivo Antibody - Low Endotoxin (29F.1A12) recognizes an epitope on Mouse PD-1. Despite its predicted molecular weight, PD-1 often migrates at higher molecular weight in SDS-PAGE. |
|---|
| 内毒素水平 | ≤ 1.0 EU/mg as determined by the LAL method |
|---|
| 纯度 | >95% by SDS-PAGE and HPLC |
|---|
| 纯化方式 | This monoclonal antibody was purified using Protein A |
|---|
| Accession号 | Q02242 |
|---|
| 状态 | Liquid |
|---|
| 保存溶液 |
0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
|
| 运输 | Blue ice |
|---|
| 产品使用信息 |
| 应用方法 |
稀释比例 |
| Western Blotting |
To detect Mouse PD-1 this antibody can be used at a concentration of 30 µg/ml.
Blocking: The 29F.1A12 antibody has been shown to block the binding of PD-1 to its ligands in vivo. For immune checkpoint antibodies 200 ug per mouse per injection is the standard dosage in the literature. NOTE: The response is model dependent. We have seen some tumor lines in mice that grow progressively. If we treat the animal with anti-PD-1 (days 3,6,9 @ 200 ug per animal per injection) then the tumor will regress, and disappear.
Each investigator should determine their own optimal working dilution for specific applications. |
|
|---|
| 稳定性和存储 | Anti-PD-1 In Vivo Antibody - Low Endotoxin (29F.1A12) is stable when stored at 2-8°C for at least four (4) weeks. For long-term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles. |
|---|
| 规格 | Size: 5mg; Aggregation: Aggregation level ≤ 5%; Fc Modification: LALAPG |
|---|
| 别名 | Programmed cell death protein 1, Pdcd1, CD279, 29F 1A12, 29F-1A12, 29F1A12 |
|---|
| 背景 | Clone 29F.1A12 is a mouse IgG2a monoclonal antibody directed against mouse PD-1 (PDCD1), supplied as a recombinantly produced reagent for reproducible lot-to-lot performance. Because it recognises and blocks the mouse ortholog, it is well suited to syngeneic tumour models and other immuno-oncology and chronic-infection studies in mice, where PD-1/PD-L1 checkpoint interference is a central experimental question. It is validated for flow cytometry, western blot, blocking assays, and IHC on frozen sections, supporting both phenotyping and functional work. ichor.bio offers this clone in a low-endotoxin (<1 EU/mg research grade; <0.5 EU/mg ultra-low) format at bulk milligram-to-gram scale, which is the practical requirement for repeated intraperitoneal dosing across treatment cohorts. The recombinant, in-vivo-ready presentation makes it appropriate for functional PD-1 blockade experiments as well as ex-vivo characterisation. All material is for research use only. The clone is a commonly cited tool for interrogating PD-1-dependent T-cell regulation in preclinical settings.
PD-1 (programmed cell death protein 1; PDCD1; UniProt Q02242) is an inhibitory immune checkpoint receptor of the CD28/CTLA-4 immunoglobulin superfamily, expressed on activated T cells, B cells, NK cells, and myeloid subsets. It is induced upon antigen engagement and is sustained at high levels on chronically stimulated and exhausted T cells. Engagement by its ligands PD-L1 (CD274) and PD-L2 (PDCD1LG2) recruits the phosphatases SHP-2 (and SHP-1) to PD-1's cytoplasmic ITIM and ITSM motifs, dampening TCR and CD28 signalling and attenuating proliferation, cytokine output, and cytotoxicity. This axis maintains peripheral tolerance and limits immunopathology, but tumours and persistent pathogens co-opt it to suppress effector responses. Antibody blockade of PD-1 interrupts ligand binding and can restore antitumour and antiviral T-cell function, the basis of checkpoint-blockade immunotherapy modelled preclinically in mice. Induced on splenic T and B lymphocytes, thymocytes, and myeloid cells after stimulation.Subset of double negative thymocytes, activated T and B cells |
|---|
| Note | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
|---|
| Isotype Control | ICH2245 |
|---|
